A Phase II Study of AZD2171 in the Treatment of Patients With Acute Leukemia and Myelodysplastic Syndrome
Latest Information Update: 10 Nov 2021
At a glance
- Drugs Cediranib (Primary)
- Indications Acute myeloid leukaemia; Myelodysplastic syndromes
- Focus Therapeutic Use
- 12 Jul 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 12 Jul 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 12 Jul 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.